Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study

Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of medical sciences Vol. 18; no. 16; pp. 3624 - 3630
Main Authors Chen, Zhong-Wei, Tang, Kun, Zhao, You-Fan, Chen, Yang-Zong, Tang, Liang-Jie, Li, Gang, Huang, Ou-Yang, Wang, Xiao-Dong, Targher, Giovanni, Byrne, Christopher D., Zheng, Xiang-Wu, Zheng, Ming-Hua
Format Journal Article
LanguageEnglish
Published Australia Ivyspring International Publisher Pty Ltd 01.01.2021
Ivyspring International Publisher
Subjects
Online AccessGet full text
ISSN1449-1907
1449-1907
DOI10.7150/ijms.64458

Cover

Abstract Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on F-fluorodeoxyglucose ( F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). A total of 22 adults with biopsy-confirmed MAFLD, who underwent F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. These preliminary data suggest that F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD.
AbstractList Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: A total of 22 adults with biopsy-confirmed MAFLD, who underwent 18F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in 18F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. Results: The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. Conclusion: These preliminary data suggest that 18F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD.Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: A total of 22 adults with biopsy-confirmed MAFLD, who underwent 18F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in 18F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. Results: The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. Conclusion: These preliminary data suggest that 18F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD.
Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on F-fluorodeoxyglucose ( F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). A total of 22 adults with biopsy-confirmed MAFLD, who underwent F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. These preliminary data suggest that F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD.
Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: A total of 22 adults with biopsy-confirmed MAFLD, who underwent 18F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in 18F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. Results: The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. Conclusion: These preliminary data suggest that 18F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD.
Author Chen, Yang-Zong
Huang, Ou-Yang
Zheng, Ming-Hua
Li, Gang
Tang, Liang-Jie
Tang, Kun
Zheng, Xiang-Wu
Targher, Giovanni
Chen, Zhong-Wei
Zhao, You-Fan
Wang, Xiao-Dong
Byrne, Christopher D.
AuthorAffiliation 4 Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China
5 Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
3 NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
7 Institute of Hepatology, Wenzhou Medical University, Wenzhou, China
1 Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
2 Department of Nuclear Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
6 Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK
AuthorAffiliation_xml – name: 4 Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China
– name: 5 Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
– name: 3 NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
– name: 2 Department of Nuclear Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
– name: 1 Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
– name: 7 Institute of Hepatology, Wenzhou Medical University, Wenzhou, China
– name: 6 Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK
Author_xml – sequence: 1
  givenname: Zhong-Wei
  surname: Chen
  fullname: Chen, Zhong-Wei
– sequence: 2
  givenname: Kun
  surname: Tang
  fullname: Tang, Kun
– sequence: 3
  givenname: You-Fan
  surname: Zhao
  fullname: Zhao, You-Fan
– sequence: 4
  givenname: Yang-Zong
  surname: Chen
  fullname: Chen, Yang-Zong
– sequence: 5
  givenname: Liang-Jie
  surname: Tang
  fullname: Tang, Liang-Jie
– sequence: 6
  givenname: Gang
  surname: Li
  fullname: Li, Gang
– sequence: 7
  givenname: Ou-Yang
  surname: Huang
  fullname: Huang, Ou-Yang
– sequence: 8
  givenname: Xiao-Dong
  surname: Wang
  fullname: Wang, Xiao-Dong
– sequence: 9
  givenname: Giovanni
  surname: Targher
  fullname: Targher, Giovanni
– sequence: 10
  givenname: Christopher D.
  surname: Byrne
  fullname: Byrne, Christopher D.
– sequence: 11
  givenname: Xiang-Wu
  surname: Zheng
  fullname: Zheng, Xiang-Wu
– sequence: 12
  givenname: Ming-Hua
  surname: Zheng
  fullname: Zheng, Ming-Hua
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34790034$$D View this record in MEDLINE/PubMed
BookMark eNp9kU2LFDEQhoOsuB968QdIwIus9JrupD_iQVhWV4URQfQc0kn1bIZ00ibp0T7uPzfjrLou4ikV6qmXqvc9RgfOO0DocUnO2rImL8xmjGcNY3V3Dx2VjPGi5KQ9uFUfouMYN4TQirblA3RIWcvzjx2h609SGz8aFXEvI2jsHR7s7IMvNPjvy9rOykfAk48mhdyE0cRocpH86NdBTlcLngJoo1LE1mwh4MH0IeMRG4d746e4FFPwW3D4w_nl6vVLLPFkrE84plkvD9H9QdoIj27eE_Tl8s3ni3fF6uPb9xfnq0Ix0qRCc5DQt7xmWndMt43kSkvVlFRpWinayw6A1YQ2lNBB9lzSrtVU1b1m0BBGT9Dzve7sJrl8k9aKKZhRhkWUROyMFDsjxU8jM_1qT09zP4JW4FKQfya8NOLvjjNXYu23oqtbXnGSBZ7dCAT_dYaYRDZOgbXSgZ-jqGqeg6l41Wb06R104-fgshk7qm4aUnU0U09ub_R7lV9ZZuB0D6jsfgww_P8-cgdWJsmUg83XGPuvkR-Ex8SW
CitedBy_id crossref_primary_10_1007_s11307_022_01740_2
crossref_primary_10_1016_j_nucmedbio_2025_108997
crossref_primary_10_3389_fphar_2024_1437479
crossref_primary_10_1186_s12880_024_01272_x
crossref_primary_10_7759_cureus_51443
crossref_primary_10_1002_VIW_20240010
ContentType Journal Article
Copyright The author(s).
2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The author(s) 2021
Copyright_xml – notice: The author(s).
– notice: 2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOI 10.7150/ijms.64458
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 4
  dbid: BENPR
  name: Proquest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1449-1907
EndPage 3630
ExternalDocumentID 10.7150/ijms.64458
PMC8579290
34790034
10_7150_ijms_64458
Genre Clinical Trial
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
29J
2WC
4.4
53G
5GY
5VS
7X7
8FI
8FJ
AAYXX
ABUWG
ACGFO
ADBBV
ADRAZ
AENEX
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
DU5
E3Z
EBS
EJD
EMOBN
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
KQ8
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PUEGO
RNS
RPM
SJN
TR2
UKHRP
W2D
WOQ
WOW
XSB
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c406t-d9eaeb7954dd84d76a9cdac613cd32c3ba8ee45036303fab9a387d3c5bd4e6043
IEDL.DBID M48
ISSN 1449-1907
IngestDate Sun Oct 26 04:02:47 EDT 2025
Tue Sep 30 16:56:09 EDT 2025
Fri Sep 05 05:29:23 EDT 2025
Tue Oct 07 07:27:00 EDT 2025
Thu Apr 03 06:59:50 EDT 2025
Wed Oct 01 03:28:25 EDT 2025
Thu Apr 24 23:10:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 16
Keywords 18F-FDG PET/CT
Metabolic dysfunction-associated fatty liver disease
Fibrosis
Radiomics
Language English
License The author(s).
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
cc-by-nc
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c406t-d9eaeb7954dd84d76a9cdac613cd32c3ba8ee45036303fab9a387d3c5bd4e6043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
Competing Interests: The authors have declared that no competing interest exists.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.7150/ijms.64458
PMID 34790034
PQID 2595660283
PQPubID 5263175
PageCount 7
ParticipantIDs unpaywall_primary_10_7150_ijms_64458
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8579290
proquest_miscellaneous_2599072927
proquest_journals_2595660283
pubmed_primary_34790034
crossref_primary_10_7150_ijms_64458
crossref_citationtrail_10_7150_ijms_64458
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Wyoming
– name: Sydney
PublicationTitle International journal of medical sciences
PublicationTitleAlternate Int J Med Sci
PublicationYear 2021
Publisher Ivyspring International Publisher Pty Ltd
Ivyspring International Publisher
Publisher_xml – name: Ivyspring International Publisher Pty Ltd
– name: Ivyspring International Publisher
SSID ssj0032371
Score 1.9112579
Snippet Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore...
Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3624
SubjectTerms Adult
Biopsy
Blood pressure
China
Cholesterol
Diabetes
Discriminant analysis
Disease Progression
Drug dosages
Fatty liver
Female
Fluorodeoxyglucose F18
Glucose
Histology
Humans
Liver Cirrhosis - diagnosis
Liver Cirrhosis - pathology
Liver diseases
Male
Medical imaging
Metabolism
Middle Aged
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - pathology
Performance evaluation
Pilot Projects
Positron Emission Tomography Computed Tomography - methods
Predictive Value of Tests
Prognosis
Radiometry - methods
Radiomics
Research Paper
Software
Tomography
Variables
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB_qFdQXqd_RKiv2xYfYXL42KxRptUcR75BioW9hs7vBSJqNlxx6j_7nzuSStKXS1-yQLDubmd_OzP4GYC8OjdAii9w4MLGL_nbqJgGVWCHczafSE1LQ3eH5Ij45C7-cR-dbsBjuwlBZ5WATO0OtraIY-T7CdEQe5A0_1r9c6hpF2dWhhYbsWyvog45i7A5s-8SMNYHto-PFt9PBNuMM-HRDUsoRCe0XPy-a94gIqOH7Vbd0A2veLJm8t6pquf4ty_KKP5rtwIMeSLLDjeYfwpapHsHdeZ8qfwx_T6Uu6Mpxw8hTaWYrlpcru7SuNvbPuq9VZ13V1hIHqfEbhc5Yay96HmtWL-l9bcNKKt9gOZ6tUbxhRcWywtbN2qWQhKnY_HD29fMHJlldlLZlHWntEzibHX__dOL2_RZchW69dbUw0mRcRKHWSah5LIXSUqHDVzrwVZDJxJgwotSvF-QyEzJIuA5UlOnQxF4YPIVJZSvzHJjyjc-FQWtgvFArKePck14ecXyY4OZw4N2w3KnqycipJ0aZ4qGEVJOSatJONQ68HWXrDQXHf6V2B62l_W_YpJebxoE34zAuJ2VFZGXsqpMRRJ_ucweebZQ8foau2RKDjwP8mvpHASLnvj5SFT86ku4k4og8PQf2xo1yy-xf3D77l3Dfp1qaLvSzC5N2uTKvEAy12et-h_8DowcQtA
  priority: 102
  providerName: ProQuest
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VrQRceD8CBRm1Fw7ZZhMnjrmtKKsKsRVCrFROkWM7IpAm0SYBlRv_nJkku2opAq7xKLEyY89nz8w3AAcRt9LINHSjwEYu-tuZGweUYoVwN5spTypJtcPLk-h4xd-ehqc7sL-phaG0SnQDuP33Yfxvs7jGLZZPa5Ndg90oRMA9gd3Vyfv5p75uiEsXXZoYiEcFopvD_MtZM0UvT03cL7qaK_jxahrkja6s1fl3VRQXfMziNhxtZjeklnyddm061T9-I278x_TvwK0RY7L5YBR3YceW9-D6coyi34efH5TJqRq5YeTEDKtKlhVdta5cY_HTYxo76xO61jhIPeHoVo211dlIcc3qNb2vbVhBmR0sw2M3ijcsL1maV3Vz7tJthS3Zcr54d_SKKVbnRdWyns_2AawWbz6-PnbHVgyuRo_fukZaZVMhQ25MzI2IlNRGacQC2gS-DlIVW8tDigp7QaZSqYJYmECHqeE28njwECZlVdrHwLRvfSEtbhTW40YrFWWe8rJQ4MMY7caBlxutJXrkKad2GUWC5xXScEIaTnoNO7C_la0Hdo4_Su1tlJ-MK7RJ8NiHSJbQlQMvtsP4Oylgokpbdb2MJGZ1XzjwaLCV7WeoApfIfRwQl6xoK0C83ZdHyvxzz98dhwJBqefAwdbe_jL7J_8n9hRu-pRu098O7cGkXXf2GeKlNn0-rpdfMfkcEg
  priority: 102
  providerName: Unpaywall
Title Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study
URI https://www.ncbi.nlm.nih.gov/pubmed/34790034
https://www.proquest.com/docview/2595660283
https://www.proquest.com/docview/2599072927
https://pubmed.ncbi.nlm.nih.gov/PMC8579290
https://www.medsci.org/v18p3624.pdf
UnpaywallVersion publishedVersion
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1449-1907
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: KQ8
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals - Free Access to All
  customDbUrl:
  eissn: 1449-1907
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: DIK
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1449-1907
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1449-1907
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: M~E
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1449-1907
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: RPM
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (Proquest)
  customDbUrl:
  eissn: 1449-1907
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: 7X7
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Proquest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1449-1907
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: BENPR
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1449-1907
  dateEnd: 20250731
  omitProxy: true
  ssIdentifier: ssj0032371
  issn: 1449-1907
  databaseCode: M48
  dateStart: 20040301
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db5RAEJ_0I9G-GL-L1ssaGxMfOCksLOuLObWXxniXpvGS84ks7BIxFOjBxd6j_7kzHEc82xgfYSew2RmY3-zM_gbgOOBGahn7duCZwEZ_e2KHHpVYIdxNT5QjlaSzw5NpcDbjn-f-fAc2RezdAta3hnbUT2q2yIfXV6v3-MEjfh0KxDNvsx-X9RD9uh--rq5saihFideuu8Yu7KPTktTVYcL7BANOZR2LcS5t9IlizVz61-O2fdUNAHqzjvLusqjU6qfK8z-c1Pg-3OvQJRutzeEB7JjiIdyZdPnzR_DrQumMziHXjNyXZmXB0nxZLkpbm_J61RWws7aUa4GD1A2O9tNYU1525NasWtDzmprlVNPBUgy4UbxmWcHirKzqlU37FKZgk9H4y6d3TLEqy8uGtUy2j2E2Pv368czumjDYCfr6xtbSKBML6XOtQ65FoGSiVYIoINGem3ixCo3hPuWDHS9VsVReKLSX-LHmJnC49wT2irIwh8AS17hCGvxFGIfrRKkgdZST-gJvhmgxFrzZLHeUdAzl1CgjjzBSIdVEpJqoVY0Fr3rZas3LcavU0UZr0ca0Igz4EMMSrrLgZT-My0mpElWYctnKSOJUd4UFT9dK7l9DZ2-J1scCsaX-XoAYu7dHiux7y9wd-gLhqGPBcW8o_5j9s_-Y3nM4cKnKpt0UOoK9ZrE0LxAmNfEAdsVcDGD_w-n0_GLQmj9ezabno2-_AV_dHBY
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVqJcEG9SChhRDhxCs4nzMFKFCu1qS3dXqGql3oITOyJVmoRNVmWP_DF-GzPZJLQq6q3XeOQknrHnsz3zDcCWx7VQInJNz9Geif52YAYOhVgh3E0G0hJSUO7wZOqNTvjXU_d0Bf50uTAUVtmtic1CrYqYzsi3EaYj8iBv-Kn8aVLVKLpd7UpoyLa0gtppKMbaxI5DvbjALVy1c7CH-n5n28P94y8js60yYMbozGpTCS115AuXKxVw5XtSxErG6OZi5dixE8lAa-7ShaflJDIS0gl85cRupLj2LO5gv3dgjTtc4OZv7fP-9NtR5wvwj_3BkhTVR-S1nZ6dVx8QgVCB-ctu8Bq2vR6iuT7PS7m4kFl2yf8NH8D9Friy3aWlPYQVnT-Cu5P2av4x_D6SKqUU54qRZ1SsyFmSzYtZYSpd_Fq0sfGsiRKbYSMVmqOjOlYX5y1vNitn1F9dsYzCRViCe3kUr1iasygtymph0hGIztlkdzje-8gkK9OsqFlDkvsETm5l5J_Cal7k-jmw2Na2LzSuPtriKpbSSyxpJa6PDwM0RgPed8Mdxi35OdXgyELcBJFqQlJN2KjGgLe9bLmk_Piv1GantbCd9lX4z0gNeNM343DSLYzMdTFvZATRtdu-Ac-WSu5fQ2m9xBhkgH9F_b0AkYFfbcnTHw0peOD6iHQtA7Z6Q7nh6zdu_vrXsD46nozD8cH08AXcsymOpzl22oTVejbXLxGI1dGr1toZfL_tCfYXpiRPSg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIhUuiG8CBYwoBw5hs3ESx0gIVSyrlnYrhKi0t-DEjghKk7DJquyRv8WvYybJhlZFvfW6HiVZz9jzbD-_AdgJPCO1jH074CawMd-O7ZATxQrhbjpWjlSS7g7PjoK9Y-_T3J9vwJ_1XRiiVa7nxHai1mVCe-QjhOmIPCgbjtKeFvF5Mn1f_bSpghSdtK7LaXQhcmBWp7h8q9_tT9DXr1x3-vHrhz27rzBgJ5jIGltLo0wspO9pHXpaBEomWiWY4hLN3YTHKjTG8-mw0-GpiqXiodA88WPtmcDxOD73GlwXnEuiE4r5sNjD_yrGnRyqQMw1yn6c1G8Qe1Bp-bMJ8AKqvUjOvLEsKrU6VXl-JvNNb8OtHrKy3S7G7sCGKe7C1qw_lL8Hv78ondHl5ppRTtSsLFiaL8tFaWtT_lr1rHjW8sMW2Egl5miTjjXlSa-YzaoFPa-pWU5EEZbiKh7Na5YVLM7Kql7ZtPlhCjbbnR5O3jLFqiwvG9bK496H4yvp9wewWZSFeQQscY0rpMF5xzieTpQKUkc5qS_wxxDD0ILX6-6Okl72nKpv5BEuf8g1Ebkmal1jwcvBturEPv5rtb32WtQP-Dr6F54WvBiasTvp_EUVply2NpKE2l1hwcPOycNr6EIvaQVZIM65fzAgGfDzLUX2vZUDD32BGNexYGcIlEu-_vHlX_8ctnBYRYf7RwdP4KZLBJ52v2kbNpvF0jxFBNbEz9pQZ_DtqsfWX6QuTOQ
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VrQRceD8CBRm1Fw7ZZhMnjrmtKKsKsRVCrFROkWM7IpAm0SYBlRv_nJkku2opAq7xKLEyY89nz8w3AAcRt9LINHSjwEYu-tuZGweUYoVwN5spTypJtcPLk-h4xd-ehqc7sL-phaG0SnQDuP33Yfxvs7jGLZZPa5Ndg90oRMA9gd3Vyfv5p75uiEsXXZoYiEcFopvD_MtZM0UvT03cL7qaK_jxahrkja6s1fl3VRQXfMziNhxtZjeklnyddm061T9-I278x_TvwK0RY7L5YBR3YceW9-D6coyi34efH5TJqRq5YeTEDKtKlhVdta5cY_HTYxo76xO61jhIPeHoVo211dlIcc3qNb2vbVhBmR0sw2M3ijcsL1maV3Vz7tJthS3Zcr54d_SKKVbnRdWyns_2AawWbz6-PnbHVgyuRo_fukZaZVMhQ25MzI2IlNRGacQC2gS-DlIVW8tDigp7QaZSqYJYmECHqeE28njwECZlVdrHwLRvfSEtbhTW40YrFWWe8rJQ4MMY7caBlxutJXrkKad2GUWC5xXScEIaTnoNO7C_la0Hdo4_Su1tlJ-MK7RJ8NiHSJbQlQMvtsP4Oylgokpbdb2MJGZ1XzjwaLCV7WeoApfIfRwQl6xoK0C83ZdHyvxzz98dhwJBqefAwdbe_jL7J_8n9hRu-pRu098O7cGkXXf2GeKlNn0-rpdfMfkcEg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Radiomics+based+on+fluoro-deoxyglucose+positron+emission+tomography+predicts+liver+fibrosis+in+biopsy-proven+MAFLD%3A+a+pilot+study&rft.jtitle=International+journal+of+medical+sciences&rft.au=Chen%2C+Zhong-Wei&rft.au=Tang%2C+Kun&rft.au=Zhao%2C+You-Fan&rft.au=Chen%2C+Yang-Zong&rft.date=2021-01-01&rft.issn=1449-1907&rft.eissn=1449-1907&rft.volume=18&rft.issue=16&rft.spage=3624&rft_id=info:doi/10.7150%2Fijms.64458&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1449-1907&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1449-1907&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1449-1907&client=summon